Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers

NCT00821535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV) Infection

Interventions

DRUG: maraviroc (Selzentry, Celsentri)

Sponsor

ViiV Healthcare

Collaborators

[object Object]